Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Coronary artery disease

Complex coronary disease in the post-SYNTAX era

Nature Reviews Cardiology volume 6, pages 397–398 (2009)Cite this article

Should patients with high-risk coronary artery disease be treated with CABG or receive drug-eluting stents? The SYNTAX trial aimed to define the optimal revascularization strategy for patients with previously untreated three-vessel and/or left main coronary artery disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Yusuf, S. et al. Effect of coronary artery bypass graft surgery on survival: overview of 10 year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344, 563–570 (1994).

    Article  CAS  Google Scholar 

  2. Jones, R. H. et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J. Thorac. Cardiovasc. Surg. 111, 1013–1025 (1996).

    Article  CAS  Google Scholar 

  3. Smith, S. C. et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of American College of Cardiology/American Heart Association task force on practice guideline (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J. Am. Coll. Cardiol. 47, e1–e121 (2006).

    Article  Google Scholar 

  4. Serruys, P. A. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 360, 961–972 (2009).

    Article  CAS  Google Scholar 

  5. Pereira, A. C. et al. Clinical judgment and treatment options in stable multivessel coronary artery disease. Results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II). J. Am. Coll. Cardiol. 48, 948–953 (2006).

    Article  Google Scholar 

  6. Tarantini, G. et al. PCI versus CABG for multivessel coronary disease in diabetics. Catheter Cardiovasc. Interv. 73, 50–58 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy

    Giuseppe Tarantini

Authors
  1. Giuseppe Tarantini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Tarantini.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tarantini, G. Complex coronary disease in the post-SYNTAX era. Nat Rev Cardiol 6, 397–398 (2009). https://doi.org/10.1038/nrcardio.2009.75

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2009.75

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing